ArticleJAMA network open2026
Hypertensive Disorders of Pregnancy and Incident Dementia.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Hypertensive disorders of pregnancy (HDPs) are established markers of later-life cardiovascular disease, but their association with dementia remains uncertain. Objective: To investigate whether HDPs are associated with incident dementia in a nationwide population-based cohort with more than 2 decades of follow-up. Design, Setting, and Participants: This retrospective cohort study used the Korean National Health Insurance Service database to identify females aged 16 years or older who delivered between January 1, 2002, and December 31, 2005, and followed up through December 31, 2024. Statistical analyses were conducted between October 2025 and May 2026. Exposures: HDPs were defined as gestational hypertension, preeclampsia, HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome, or eclampsia. Main Outcomes and Measures: The primary outcome was incident dementia, including Alzheimer disease and vascular dementia. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% CIs. Results: Among 1 370 485 females (mean [SD] age, 29.2 [3.9] years), 28 747 (2.1%) experienced HDPs. The cumulative incidence of dementia was higher among females with HDPs than among those without HDPs (7.2 vs 2.8 per 10 000 females; P < .001), as was the incidence density of dementia (3.00 vs 1.05 per 100 000 person-years; P < .001). In model 1, HDPs were associated with an increased risk of incident dementia after adjustment for baseline maternal, socioeconomic, and obstetric factors (adjusted HR, 1.96; 95% CI, 1.19-3.23). In model 2, after additional adjustment for postdelivery hypertension, diabetes, myocardial infarction, and stroke, the association was attenuated and was no longer statistically significant (adjusted HR, 1.15; 95% CI, 0.70-1.91). Conclusions and Relevance: In this cohort study, HDPs were associated with an increased risk of incident dementia after adjustment for baseline maternal, socioeconomic, and obstetric factors. However, this association was no longer statistically significant after additional adjustment for postdelivery vascular and metabolic conditions. Given the small number of dementia events among females with HDPs, these findings should be interpreted cautiously. These findings suggest that HDPs may serve as an early-life marker of long-term neurovascular vulnerability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.